Moderna and Merck & Co. have developed a cancer vaccine that cuts the risk of death or recurrence of most deadly skin cancer by 44 percent compared to Merck's Keytruda on its own, according to researchers. 

Share:
More In Science
Earth in Danger Zone in Nearly All Ecological Ways, Study Says
Earth has pushed past seven out of eight scientifically established safety limits and into “the danger zone,” not just for an overheating planet that's losing its natural areas, but for the well-being of people living on it, according to a new study.
Load More